A roughly $7 million vascular clinic is headed for the Broad Avenue Gateway development, bringing a dedicated vascular center to a stretch of Memphis that has been hit especially hard by kidney disease. The 12,000-square-foot facility will be operated by Bluff City Vascular in partnership with Lifeline Surgical Partners and is expected to open in 2027.
According to the Memphis Business Journal, the project carries an estimated $7 million price tag, will occupy roughly 12,000 square feet, and is aimed squarely at serving dialysis patients in neighborhoods with above-average rates of kidney disease. Construction is scheduled to begin in March, with the center targeting a 2027 opening for patients.
State regulators have already helped move the plan along, and trade coverage has tracked both the project and its physician leadership. Becker's ASC reported that the ambulatory surgical center cleared the State of Tennessee Health Facilities Commission in 2024, and Interventional News notes that Omar Davis serves as president and medical director of Bluff City Vascular and has participated in national dialysis registries.
Where It Will Sit
The new center is planned as part of the Broad Avenue Gateway mixed-use development at the corner of Sam Cooper and Tillman streets, where the first phase with a Ramblin’ Joe’s coffee shop and a Chase branch is already under construction. The Daily Memphian and commercial listings place the vascular clinic site at 2977 Broad Ave, with the space slated for the project’s second phase.
How It Could Help Dialysis Patients
Outpatient vascular centers like this one can perform same-day access maintenance and related procedures that help keep dialysis patients out of the hospital and get their access sites repaired more quickly. That seemingly small difference can determine whether someone spends an afternoon in a clinic or several days in an inpatient bed.
National data highlight why that matters. The CDC reports that dialysis patients face far higher rates of bloodstream infections and significant racial disparities in outcomes, and the National Kidney Foundation outlines the broader and growing burden of chronic kidney disease across the United States.
Developers and Bluff City Vascular did not immediately respond to requests for comment, but industry coverage suggests Lifeline Surgical Partners has been building out operational services designed to smooth the rollout of new outpatient sites. Infection Control Today reports that Lifeline has rebranded and leaned into offsite sterilization services, and local permitting will ultimately determine whether the Broad Avenue project stays on its projected timetable.
